Amgen Inc. (AMGN)
NASDAQ: AMGN · Real-Time Price · USD
344.72
-4.86 (-1.39%)
Jun 8, 2026, 2:33 PM EDT - Market open
Amgen Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 12,038 | 9,129 | 11,973 | 10,944 | 7,629 | 7,989 |
Short-Term Investments | - | - | - | - | 1,676 | 48 |
Cash & Short-Term Investments | 12,038 | 9,129 | 11,973 | 10,944 | 9,305 | 8,037 |
Cash Growth | 36.64% | -23.75% | 9.40% | 17.61% | 15.78% | -24.51% |
Accounts Receivable | 9,138 | 9,570 | 6,782 | 7,268 | 5,563 | 4,895 |
Inventory | 6,186 | 6,225 | 6,998 | 9,518 | 4,930 | 4,086 |
Other Current Assets | 4,113 | 4,133 | 3,277 | 2,602 | 2,388 | 2,367 |
Total Current Assets | 31,475 | 29,057 | 29,030 | 30,332 | 22,186 | 19,385 |
Net Property, Plant & Equipment | 8,216 | 7,913 | 6,543 | 5,941 | 5,427 | 5,184 |
Other Intangible Assets | 21,379 | 22,276 | 27,699 | 32,641 | 16,080 | 15,182 |
Goodwill | 18,674 | 18,680 | 18,637 | 18,629 | 15,529 | 14,890 |
Other Long-Term Assets | 12,760 | 12,660 | 9,930 | 9,611 | 5,899 | 6,524 |
Total Assets | 92,504 | 90,586 | 91,839 | 97,154 | 65,121 | 61,165 |
Accounts Payable | 2,935 | 2,367 | 1,908 | 1,590 | 1,572 | 1,366 |
Accrued Expenses | 16,583 | 18,523 | 17,641 | 15,359 | 12,524 | 10,731 |
Current Portion of Long-Term Debt | 5,437 | 4,599 | 3,550 | 1,443 | 1,591 | 87 |
Total Current Liabilities | 24,955 | 25,489 | 23,099 | 18,392 | 15,687 | 12,184 |
Long-Term Debt | 51,886 | 50,005 | 56,549 | 63,170 | 37,354 | 33,222 |
Other Long-Term Liabilities | 6,473 | 6,434 | 6,314 | 9,360 | 8,419 | 9,059 |
Total Long-Term Liabilities | 58,359 | 56,439 | 62,863 | 72,530 | 45,773 | 42,281 |
Total Liabilities | 83,314 | 81,928 | 85,962 | 90,922 | 61,460 | 54,465 |
Common Stock | 34,030 | 34,023 | 33,533 | 33,070 | 32,514 | 32,096 |
Accumulated Other Comprehensive Income | -190 | -258 | -66 | -289 | -231 | -796 |
Retained Earnings | -24,650 | -25,107 | -27,590 | -26,549 | -28,622 | -24,600 |
Shareholders' Equity | 9,190 | 8,658 | 5,877 | 6,232 | 3,661 | 6,700 |
Total Liabilities & Equity | 92,504 | 90,586 | 91,839 | 97,154 | 65,121 | 61,165 |
Total Debt | 57,323 | 54,604 | 60,099 | 64,613 | 38,945 | 33,309 |
Net Cash (Debt) | -45,285 | -45,475 | -48,126 | -53,669 | -29,640 | -25,272 |
Net Cash Per Share | -83.47 | -83.90 | -88.96 | -99.76 | -54.79 | -44.10 |
Book Value | 9,190 | 8,658 | 5,877 | 6,232 | 3,661 | 6,700 |
Book Value Per Share | 16.94 | 15.97 | 10.86 | 11.58 | 6.77 | 11.69 |
Tangible Book Value | -30,863 | -32,298 | -40,459 | -45,038 | -27,948 | -23,372 |
Tangible Book Value Per Share | -56.89 | -59.59 | -74.79 | -83.71 | -51.66 | -40.79 |